Genetic Update on Inflammatory Factors in Ulcerative Colitis: Review of the Current Literature

Overview

Journal World J Gastrointest Pathophysiol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2014 Aug 19

PMID 25133031

Citations 15

Authors

Patricia Sarlos

Erzsebet Kovesdi

Lili Magyari

Zsolt Banfai

Andras Szabo

Andras Javorhazy

Bela Melegh

Affiliations

Soon will be listed here.

Abstract

Ulcerative colitis (UC) is one of the main types of inflammatory bowel disease, which is caused by dysregulated immune responses in genetically predisposed individuals. Several genetic factors, including interleukin and interleukin receptor gene polymorphisms and other inflammation-related genes play central role in mediating and modulating the inflammation in the human body, thereby these can be the main cause of development of the disease. It is clear these data are very important for understanding the base of the disease, especially in terms of clinical utility and validity, but summarized literature is exiguous for challenge health specialist that can used in the clinical practice nowadays. This review summarizes the current literature on inflammation-related genetic polymorphisms which are associated with UC. We performed an electronic search of Pubmed Database among publications of the last 10 years, using the following medical subject heading terms: UC, ulcerative colitis, inflammation, genes, polymorphisms, and susceptibility.

Citing Articles

Artificial intelligence and machine learning technologies in ulcerative colitis.

Kulkarni C, Liu D, Fardeen T, Dickson E, Jang H, Sinha S Therap Adv Gastroenterol. 2024; 17:17562848241272001.

PMID: 39247718 PMC: 11378191. DOI: 10.1177/17562848241272001.

Concomitant ulcerative colitis and Usher syndrome in a Pakistani patient: A novel case report.

Siddiqui F, Ashkar A, Aamir S SAGE Open Med Case Rep. 2024; 12:2050313X241272501.

PMID: 39157038 PMC: 11329895. DOI: 10.1177/2050313X241272501.

Pharmacogenetic Effect of Thiopurine Methyl Transferase (TPMT) Gene Expression and Serum TNF on the Imuran Response in Ulcerative Colitis (UC) Iraqi Patients.

Ali N, Abdulkareem R Rep Biochem Mol Biol. 2024; 12(3):438-447.

PMID: 38618257 PMC: 11015922. DOI: 10.61186/rbmb.12.3.438.

Molecular analyses of ADAMTS-1, -4, -5, and IL-17 a cytokine relationship in patients with ulcerative colitis.

Buran T, Batir M, Cam F, Kasap E, Collu F, Celebi H BMC Gastroenterol. 2023; 23(1):345.

PMID: 37798683 PMC: 10552413. DOI: 10.1186/s12876-023-02985-z.

Curcumin alleviates experimental colitis a potential mechanism involving memory B cells and Bcl-6-Syk-BLNK signaling.

Wei S, Wu T, Huang J, Kang Z, Wang M, Zhong Y World J Gastroenterol. 2022; 28(40):5865-5880.

PMID: 36353208 PMC: 9639655. DOI: 10.3748/wjg.v28.i40.5865.

References

Zhang D, Zhang G, Hayden M, Greenblatt M, Bussey C, Flavell R . A toll-like receptor that prevents infection by uropathogenic bacteria. Science. 2004; 303(5663):1522-6. DOI: 10.1126/science.1094351. View

Vatay A, Bene L, Kovacs A, Prohaszka Z, Szalai C, Romics L . Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease. Immunogenetics. 2003; 55(4):247-52. DOI: 10.1007/s00251-003-0575-8. View

Hampe J, Shaw S, Saiz R, Leysens N, Lantermann A, Mascheretti S . Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet. 1999; 65(6):1647-55. PMC: 1288375. DOI: 10.1086/302677. View

Cordon-Cardo C, OBrien J, CASALS D, Biedler J, Melamed M, Bertino J . Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci U S A. 1989; 86(2):695-8. PMC: 286540. DOI: 10.1073/pnas.86.2.695. View

Kobori A, Yagi Y, Imaeda H, Ban H, Bamba S, Tsujikawa T . Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. J Gastroenterol. 2010; 45(10):999-1007. DOI: 10.1007/s00535-010-0245-1. View

Festen E, Goyette P, Scott R, Annese V, Zhernakova A, Lian J . Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis. Gut. 2009; 58(6):799-804. PMC: 2757103. DOI: 10.1136/gut.2008.166918. View

Hirv K, Seyfarth M, Uibo R, Kull K, Salupere R, Latza U . Polymorphisms in tumour necrosis factor and adhesion molecule genes in patients with inflammatory bowel disease: associations with HLA-DR and -DQ alleles and subclinical markers. Scand J Gastroenterol. 1999; 34(10):1025-32. DOI: 10.1080/003655299750025147. View

Ho G, Moodie F, Satsangi J . Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease?. Gut. 2003; 52(5):759-66. PMC: 1773632. DOI: 10.1136/gut.52.5.759. View

Reinisch W, Sandborn W, Hommes D, DHaens G, Hanauer S, Schreiber S . Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial. Gut. 2011; 60(6):780-7. DOI: 10.1136/gut.2010.221127. View

10.

Ghoreschi K, Laurence A, OShea J . Janus kinases in immune cell signaling. Immunol Rev. 2009; 228(1):273-87. PMC: 2782696. DOI: 10.1111/j.1600-065X.2008.00754.x. View

11.

Jostins L, Ripke S, Weersma R, Duerr R, McGovern D, Hui K . Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012; 491(7422):119-24. PMC: 3491803. DOI: 10.1038/nature11582. View

12.

Houlston R, Webb E, Broderick P, Pittman A, Di Bernardo M, Lubbe S . Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet. 2008; 40(12):1426-35. PMC: 2836775. DOI: 10.1038/ng.262. View

13.

Bouma G, Crusius J, Garcia-Gonzalez M, Meijer B, Hellemans H, Hakvoort R . Genetic markers in clinically well defined patients with ulcerative colitis (UC). Clin Exp Immunol. 1999; 115(2):294-300. PMC: 1905167. DOI: 10.1046/j.1365-2249.1999.00797.x. View

14.

Sandborn W, Van Assche G, Reinisch W, Colombel J, DHaens G, Wolf D . Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology. 2011; 142(2):257-65.e1-3. DOI: 10.1053/j.gastro.2011.10.032. View

15.

Bruewer M, Luegering A, Kucharzik T, Parkos C, Madara J, Hopkins A . Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol. 2003; 171(11):6164-72. DOI: 10.4049/jimmunol.171.11.6164. View

16.

Jabalameli M . Role of STAT3 Locus in autoimmune diseases. Genes Immun. 2011; 12(2):155. DOI: 10.1038/gene.2010.55. View

17.

Cantor M, Nickerson P, Bernstein C . The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease. Am J Gastroenterol. 2005; 100(5):1134-42. DOI: 10.1111/j.1572-0241.2005.40979.x. View

18.

Walczak A, Przybylowska K, Dziki L, Sygut A, Chojnacki C, Chojnacki J . The lL-8 and IL-13 gene polymorphisms in inflammatory bowel disease and colorectal cancer. DNA Cell Biol. 2012; 31(8):1431-8. PMC: 3405451. DOI: 10.1089/dna.2012.1692. View

19.

Steeber D, Green N, Sato S, Tedder T . Humoral immune responses in L-selectin-deficient mice. J Immunol. 1996; 157(11):4899-907. View

20.

Balding J, Kane D, Livingstone W, Mynett-Johnson L, Bresnihan B, Smith O . Cytokine gene polymorphisms: association with psoriatic arthritis susceptibility and severity. Arthritis Rheum. 2003; 48(5):1408-13. DOI: 10.1002/art.10935. View